- Pfizer’s In-Line Guidance Offers Relief to Weary Investors
Pfizer Inc. forecast 2025 revenue in line with analysts' projections, a
step toward fending off an activist investor's claims that the...
from: Bloomberg.com
|
- Pfizer Projects Strong Financial Growth for 2025
Pfizer ( ($PFE) ) just unveiled an announcement. Pfizer has announced its
financial guidance for the full year 2025, projecting revenues...
from: TipRanks
|
- Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64
Billion
Pfizer anticipates adjusted earnings of between $2.80 and $3 a share in
2025. Analysts had been expecting adjusted earnings of $2.86.
from: Barron's
|
- Pfizer Analyst And Investor Call At 8:30 AM ET
(RTTNews) - Pfizer Inc. (PFE) will host its Analyst and Investor Call at
8:30 AM ET on Dec. 17, 2024, to discuss its full-year 2025...
from: Nasdaq
|
- Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024
Guidance
Full-Year 2025 Revenue Guidance(1) Range of $61.0 to $64.0 Billion.
Full-Year 2025 Adjusted(2) Diluted EPS Guidance Range of $2.80 to $3.00.
from: Yahoo Finance
|
- Pfizer looks to end year on a high with in-line guidance for 2025
Pfizer gave investors an early Christmas gift on Tuesday, announcing
guidance for next year that is broadly in line with analyst estimates,...
from: FirstWord Pharma
|
- Pfizer projects 2025 earnings to align with expectations
Pfizer Inc. (NYSE:PFE) announced on Tuesday that it anticipates its profits
for the year 2025 to align closely with current Wall Street...
from: Investing.com
|
- PFE, TSLA, SEDG, RCAT and more
Check out the companies making headlines in premarket trading. Pfizer — The
drugmaker's stock climbed more than 2% in premarket trading...
from: Qrius
|
- Pfizer unveils 2025 forecast: Stability in sight amid post-pandemic
challenges
The company projects annual revenues between $61 billion and $64 billion,
with adjusted earnings per share (EPS) expected to range from...
from: theafricalogistics.com
|
- Pfizer Sees 2025 Revenue in Line With Wall Street Views -- Update
By Sabela Ojea Pfizer forecast 2025 revenue and earnings in line with
market expectations, despite an expected $1 billion hit from the redesign
of federal...
from: marketscreener.com
|
- Pfizer Projects Strong Financial Growth for 2025
Pfizer ( ($PFE) ) just unveiled an announcement. Pfizer has announced its
financial guidance for the full year 2025, projecting revenues...
from: TipRanks
|
- Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64
Billion
Pfizer anticipates adjusted earnings of between $2.80 and $3 a share in
2025. Analysts had been expecting adjusted earnings of $2.86.
from: Barron's
|
- Pfizer Analyst And Investor Call At 8:30 AM ET
(RTTNews) - Pfizer Inc. (PFE) will host its Analyst and Investor Call at
8:30 AM ET on Dec. 17, 2024, to discuss its full-year 2025...
from: Nasdaq
|
- Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024
Guidance
Full-Year 2025 Revenue Guidance(1) Range of $61.0 to $64.0 Billion.
Full-Year 2025 Adjusted(2) Diluted EPS Guidance Range of $2.80 to $3.00.
from: Yahoo Finance
|
- Pfizer looks to end year on a high with in-line guidance for 2025
Pfizer gave investors an early Christmas gift on Tuesday, announcing
guidance for next year that is broadly in line with analyst estimates,...
from: FirstWord Pharma
|
- Pfizer projects 2025 earnings to align with expectations
Pfizer Inc. (NYSE:PFE) announced on Tuesday that it anticipates its profits
for the year 2025 to align closely with current Wall Street...
from: Investing.com
|
- PFE, TSLA, SEDG, RCAT and more
Check out the companies making headlines in premarket trading. Pfizer — The
drugmaker's stock climbed more than 2% in premarket trading...
from: Qrius
|
- Pfizer unveils 2025 forecast: Stability in sight amid post-pandemic
challenges
The company projects annual revenues between $61 billion and $64 billion,
with adjusted earnings per share (EPS) expected to range from...
from: theafricalogistics.com
|
- Pfizer Sees 2025 Revenue in Line With Wall Street Views -- Update
By Sabela Ojea Pfizer forecast 2025 revenue and earnings in line with
market expectations, despite an expected $1 billion hit from the redesign
of federal...
from: marketscreener.com
|
